Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma.
Ziccheddu B, Biancon G, Bagnoli F, De Philippis C, Maura F, Rustad EH, Dugo M, Devecchi A, De Cecco L, Sensi M, Terragna C, Martello M, Bagratuni T, Kastritis E, Dimopoulos MA, Cavo M, Carniti C, Montefusco V, Corradini P, Bolli N. Ziccheddu B, et al. Among authors: dimopoulos ma. Blood Adv. 2020 Mar 10;4(5):830-844. doi: 10.1182/bloodadvances.2019000779. Blood Adv. 2020. PMID: 32126144 Free PMC article.
Thalidomide in the treatment of multiple myeloma.
Kastritis E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Best Pract Res Clin Haematol. 2007 Dec;20(4):681-99. doi: 10.1016/j.beha.2007.09.001. Best Pract Res Clin Haematol. 2007. PMID: 18070713 Review.
Treatment of relapsed/refractory multiple myeloma.
Kastritis E, Palumbo A, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Semin Hematol. 2009 Apr;46(2):143-57. doi: 10.1053/j.seminhematol.2009.01.004. Semin Hematol. 2009. PMID: 19389498 Review.
Treatment options for relapsed and refractory multiple myeloma.
Nooka AK, Kastritis E, Dimopoulos MA, Lonial S. Nooka AK, et al. Among authors: dimopoulos ma. Blood. 2015 May 14;125(20):3085-99. doi: 10.1182/blood-2014-11-568923. Epub 2015 Apr 2. Blood. 2015. PMID: 25838342 Free article. Review.
Daratumumab combinations: what can we learn?
Kastritis E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Blood. 2017 Aug 24;130(8):957-958. doi: 10.1182/blood-2017-07-793349. Blood. 2017. PMID: 28838937 Free article. No abstract available.
Disease control should be the goal of therapy for WM patients.
Kastritis E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Blood Adv. 2017 Nov 28;1(25):2483-2485. doi: 10.1182/bloodadvances.2017005645. eCollection 2017 Nov 28. Blood Adv. 2017. PMID: 29296898 Free PMC article.
How I treat relapsed multiple myeloma.
Kastritis E, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Blood. 2022 May 12;139(19):2904-2917. doi: 10.1182/blood.2020008734. Blood. 2022. PMID: 35007326 Free article.
Management of relapsed and relapsed refractory myeloma.
Kastritis E, Mitsiades CS, Dimopoulos MA, Richardson PG. Kastritis E, et al. Among authors: dimopoulos ma. Hematol Oncol Clin North Am. 2007 Dec;21(6):1175-215, x. doi: 10.1016/j.hoc.2007.08.014. Hematol Oncol Clin North Am. 2007. PMID: 17996594 Review.
Targeted therapies in multiple myeloma.
Kastritis E, Charidimou A, Varkaris A, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Target Oncol. 2009 Jan;4(1):23-36. doi: 10.1007/s11523-008-0102-9. Epub 2009 Jan 17. Target Oncol. 2009. PMID: 19343299 Review.
1,298 results